Oxylipins as therapeutic indicators of herbal medicines in cardiovascular diseases: a review

Oxylipins as therapeutic indicators of herbal medicines in cardiovascular diseases: a review

Globally, cardiovascular diseases (CVDs) remain the leading cause of death, and their prevention and treatment continue to face major challenges. Oxylipins, as novel circulating markers of cardiovascular disease, are crucial mediators linking cardiovascular risk factors such as inflammation and plat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mengqi Li, Min He, Mengmeng Sun, Yongping Li, Mengyuan Li, Xiaobo Jiang, Yanxin Wang, Hongfeng Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Pharmacology
Subjects:	herbal medicine cardiovascular disease polyunsaturated fatty acids oxylipins review
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1454348/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development of a Liquid Chromatography–Tandem Mass Spectrometry Method for Oxylipin Analysis and Its Application to Children’s Plasma
by: Yonghan Li, et al.
Published: (2025-07-01)

Altered polyunsaturated fatty acids and oxylipins profile in Behçet’s disease
by: Mohamed Kacem Ben-Fradj, et al.
Published: (2025-05-01)

Lipid imbalance and inflammatory oxylipin cascade at the maternal-fetal interface in recurrent spontaneous abortion
by: Hao Liu, et al.
Published: (2024-12-01)

Potential of Plasma Oxylipin Signature to Better Understand the Relationships between Diet, Fatty Acids and Oxylipins in Healthy Individuals: New Insights from Two Independent Cohort Studies
by: Cécile Gladine, et al.
Published: (2024-02-01)

New functions of oxylipins released by pyroptotic cells
by: Hui Xu, et al.
Published: (2024-12-01)

ATP Alters the Oxylipin Profiles in Astrocytes: Modulation by High Glucose and Metformin
by: Alexey I. Drozhdev, et al.
Published: (2025-03-01)

Effects of molecular interactions between the exposome and oxylipin metabolism on healthspan
by: Jennifer Hinman, et al.
Published: (2025-07-01)

Adipose tissue oxylipin profile changes with subclinical ketosis and depot in postpartum dairy cows
by: Bridger B. Sparks, et al.
Published: (2025-01-01)

Activation of Nuclear Factor Erythroid 2-Related Factor-2 by Oxylipin from <i>Mangifera indica</i> Leaves
by: Atif Ali Khan Khalil, et al.
Published: (2024-09-01)

The oxylipins profile and their associations with embryo quality of women with polycystic ovary syndrome: a prospective cohort study
by: Ye Tian, et al.
Published: (2025-12-01)

The prognostic and therapeutic significance of polyunsaturated fatty acid‐derived oxylipins in ST‐segment elevation myocardial infarction
by: Zhiyong Du, et al.
Published: (2025-02-01)

Oxylipins in Aqueous Humor of Primary Open-Angle Glaucoma Patients
by: Jianming Xu, et al.
Published: (2024-09-01)

Understanding the role of oxylipins in Cannabis to enhance cannabinoid production
by: Gayathree I. Senevirathne, et al.
Published: (2025-04-01)

Time Course of Plasma Proteomic and Oxylipin Changes Induced by LPS Challenge and Modulated by Antioxidant Supplementation in a Randomized Controlled Trial
by: Gerhard Hagn, et al.
Published: (2025-04-01)

Dynamics of oxylipin biosynthesis in systemic inflammation: insights from a large animal model of endotoxemia
by: Madison N. Myers, et al.
Published: (2025-06-01)

Mitochondrial function: A new direction for the targeted treatment of cardiovascular diseases with Chinese herbal medicine
by: Lin Yang, et al.
Published: (2025-03-01)

Effects of n-3 Polyunsaturated Fatty Acid Supplementation on Cardiovascular Indices in Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials
by: Ruiyao Li, et al.
Published: (2025-02-01)

DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES
by: N. V. Perova, et al.
Published: (2016-01-01)

Oxidative Stress in Poultry and the Therapeutic Role of Herbal Medicine in Intestinal Health
by: Yuan Li, et al.
Published: (2024-11-01)

Nutraceutical support in the prevention and treatment of cardiovascular diseases
by: E. V. Gracheva, et al.
Published: (2023-07-01)

The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy
by: Victoria A. Serhiyenko, et al.
Published: (2019-03-01)

Medicinal herbal mixture for the treatment of oral diseases
by: K. A. Zavadich, et al.
Published: (2025-06-01)

Polyunsaturated Fatty Acids: Impact on Health and Disease Status
by: Samina Akbar, et al.
Published: (2021-04-01)

Role of omega-3 polyunsaturated fatty acids in cardiovascular risk management
by: V. I. Podzolkov, et al.
Published: (2020-07-01)

THE STUDY FOR THE PHARMACY RANGE OF HERBAL MEDICINAL PRODUCTS
by: O. A. Rusakova, et al.
Published: (2015-12-01)

Effect of diet low in omega-6 polyunsaturated fatty acids on the global burden of cardiovascular diseases and future trends: evidence from the Global Burden of Disease 2021
by: Qingsong Mao, et al.
Published: (2025-01-01)

Hypertriglyceridemia (triglyceride-rich lipoproteins and their remnants): role in the development of atherosclerotic cardiovascular diseases and control strategy. Opinion of the Expert Committee of the Russian Society of Cardiology, the National Atherosclerosis Society, and the Russian Society of Cardiac and Somatic Rehabilitation and Secondary Prevention
by: M. G. Bubnova, et al.
Published: (2025-07-01)

ω3-polyunsarturated fatty acid medications in cardiovascular event prevention
by: K. A. Talitsky, et al.
Published: (2006-12-01)

OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
by: A. V. Govorin, et al.
Published: (2015-12-01)

Prospects for the use of herbal medicine in the treatment of patients with non-alcoholic fatty liver disease
by: V. A. Akhmedov, et al.
Published: (2021-06-01)

Association between polyunsaturated fatty acids dietary intake and pulmonary function among American children: NHANES 2007–2012
by: Mengmeng Ding, et al.
Published: (2025-05-01)

The platelet and plasma proteome and targeted lipidome in postpartum dairy cows with elevated systemic inflammation
by: Jillian M. Grantz, et al.
Published: (2024-12-01)

The role of Chinese herbal medicine in the regulation of oxidative stress in treating hypertension: from therapeutics to mechanisms
by: Zixuan Jin, et al.
Published: (2024-10-01)

Antiarrhythmic and Hemodynamic Effects of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases
by: A. N. Zakirova, et al.
Published: (2022-05-01)

Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics
by: G. P. Arutyunov, et al.
Published: (2019-05-01)

Association between saturated and polyunsaturated fatty acid proportions in total fat intake and mortality risk: mediation by the neutrophil percentage-to-albumin ratio
by: Yanyan Liu, et al.
Published: (2025-05-01)

Gut-brain axis and vascular dementia: a review on mechanisms and Chinese herbal medicine therapeutics
by: Dexiu Wang, et al.
Published: (2025-05-01)

PUFA from microalgae: Challenges, factors affecting high production and industrial application
by: Muhammad Faiz Zakaria, et al.
Published: (2025-07-01)

Recurrent bronchitis immunomodulation in children with vertebrobasilar arterial system syndrome
by: L. S. Ovcharenko, et al.
Published: (2020-12-01)

Carcass Characteristics and Meat Quality of Broiler Chickens Fed Diets with Chlorella Vulgaris and Probiotic
by: VP Dinalli, et al.
Published: (2024-10-01)